Aspire-lakewood Holdings, Inc. balance sheet
At the end of fiscal 2025, Aspire-lakewood Holdings, Inc. had total assets of $1.3m, total liabilities of $7.7m and shareholders' equity of −$6.4m. It held $1.0m in cash against $1.3m of debt: net debt of $286,572.
Balance sheet
| Fiscal year | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|
| Cash and equivalents | 1 | 12 |
| Inventory | 0 | 0 |
| Total current assets | 1 | 13 |
| Total assets | 1 | 14 |
| Accounts payable | 1 | 1 |
| Total current liabilities | 8 | 2 |
| Total debt | 1 | 0 |
| Total liabilities | 8 | 2 |
| Shareholders' equity | −6 | 12 |
| Net debt (negative = net cash) | 0 | −12 |
| Shares outstanding | — | 1m |
| Quarter | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|
| Inventory | 0 | 0 | 0 | 0 |
| Total current assets | 2 | 1 | 7 | 13 |
| Total assets | 2 | 1 | 7 | 14 |
| Accounts payable | 1 | 1 | 1 | 1 |
| Total current liabilities | 14 | 8 | 3 | 2 |
| Total liabilities | 14 | 8 | 3 | 2 |
| Shareholders' equity | −11 | −6 | 4 | 12 |
| Shares outstanding | 50m | 118m | — | 1m |
Compare with peers
- Akanda Corp. balance sheet
- PRF Technologies Ltd. balance sheet
- Scienture Holdings, Inc. balance sheet
- 60 Degrees Pharmaceuticals, Inc. balance sheet
- China SXT Pharmaceuticals, Inc. balance sheet
Head to head: AKAN vs ASBPASBP vs PRFXASBP vs SCNX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies